Sung Hee Lim - Publications, H-index & Citations

Sung Hee Lim

Samsung Medical Center

35H指数

187论文数

4.7K被引数

收录论文 53

发表时间

Real-world genomic landscape of FGFR2 amplifications and fusions in solid tumors: analysis of 4,953 patients using clinical-grade NGS FGFR2扩增和融合在实体瘤中的真实世界基因组景观：基于临床级NGS对4,953例患者的分析

BMC Cancer

IF3.4

2026-08-14

OAAI

Ji Eun Shin; Sujin Hyung; Minsuk Kwon; Seung Tae Kim; Jeeyun Lee; Sung Hee Lim; Soomin Ahn

Efficacy of immune checkpoint inhibitor plus chemotherapy in ARID1A-mutated advanced gastric cancer ARID1A突变型晚期胃癌中免疫检查点抑制剂联合化疗的疗效

Therapeutic Advances in Gastroenterology

IF3.4

2026-05-15

PREAI

Ji Eun Shin; Eunbyeol Lee; Sung Hee Lim; Jeeyun Lee; Seung Tae Kim

Cold-spot driven local failure after stereotactic body radiation therapy for colorectal liver metastases 冷点驱动下的局部失败：结直肠癌肝转移灶立体定向体部放射治疗后的研究

Frontiers in Oncology

IF3.3

2026-04-17

OAAI

HS Hyunju Shin; JI Jeong Il Yu; HC Hee Chul Park; SH Sang Hoon Seo; SH Seong Hyeon Yun; WY Woo Yong Lee; HC Hee Cheol Kim; YB Yong Beom Cho; YA Yoon Ah Park; JW Jung Wook Huh; JK Jung Kyong Shin; YS Young Suk Park; JL Jeeyun Lee; ST Seung Tae Kim; SH Sung Hee Lim; JE Ji Eun Shin; NK Nalee Kim

Nivolumab plus chemotherapy in metastatic gastric cancer with low combined positive score 纳武利尤单抗联合化疗在低联合阳性评分的转移性胃癌中的应用

Therapeutic Advances in Gastroenterology

IF3.4

2025-11-29

OAAI

Junkyu Kim; Changgon Kim; Ji Eun Shin; Sung Hee Lim; Jeeyun Lee; Seung Tae Kim

Efficacy of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric Cancer Stratified by PD-L1 Expression: A Real-World Comparison PD-L1表达分层下，一线纳武利尤单抗联合化疗在晚期胃癌中的疗效：一项真实世界比较研究

Cancers 2025, Vol. 17, Page 3716

IF4.4

2025-11-20

OAAI

Dae-Ho Choi; Ji Eun Shin; Eunbyeol Lee; Seung Tae Kim; Sung Hee Lim

Prevalence and clinical implications of PIK3CA aberrations across cancer types: A real-world next-generation sequencing approach PIK3CA异常在不同癌症类型中的流行率及临床意义：一种真实世界下一代测序方法

CANCER GENETICS

IF2.1

2025-09-01

PREAI

Kim, Junkyu; Jang, Hye-Lim; Hong, Jung Young; Kim, Seung Tae; Park, Se Hoon; Park, Joon Oh; Kim, Kyoung-Mee; Kim, Deok geun; Lee, Jeeyun; Lim, Sung Hee

Comprehensive analysis of KRAS aberrations in pan-cancer, with a focus on prognostic and therapeutic implications 泛癌中KRAS异常的全面分析，重点关注预后和治疗意义

Therapeutic Advances in Medical Oncology

IF4.2

2025-08-17

PREAI

Jaeyun Jung; Jung Yong Hong; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Jeeyun Lee; Sang Yun Ha; Soomin Ahn; Sung Hee Lim; Seung Tae Kim

Angiogenesis gene signatures in patient-derived tumor spheroids for genetic and tumor angiogenesis profiling 患者来源肿瘤球中的血管生成基因特征，用于遗传和肿瘤血管生成分析

j mater chem a

IF0

2025-08-07

PREAI

Sujin Hyung ‡; Jihoon Ko ‡; Minae An ‡; Seung Tae Kim; Se Hoon Park; Jung Yong Hong; Sung Hee Lim; Kyoung-Mee Kim; Jeeyun Lee

Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)韩国胃癌实践指南2024: 基于证据的多学科方法 (更新2022年指南)

gastric cancer

IF3.8

2025-01-01

PREAI

Kim, In-Ho; Kang, Seung Joo; Choi, Wonyoung; Seo, An Na; Eom, Bang Wool; Kang, Beodeul; Kim, Bum Jun; Min, Byung-Hoon; Tae, Chung Hyun; Choi, Chang In; Lee, Choong-kun; An, Ho Jung; Byun, Hwa Kyung; Im, Hyeon-Su; Kim, Hyung-Don; Cho, Jang Ho; Pak, Kyoungjune; Kim, Jae-Joon; Bae, Jae Seok; Yu, Jeong Il; Lee, Jeong Won; Choi, Jungyoon; Kim, Jwa Hoon; Choi, Miyoung; Jung, Mi Ran; Seo, Nieun; Eom, Sang Soo; Ahn, Soomin; Kim, Soo Jin; Lee, Sung Hak; Lim, Sung Hee; Kim, Tae-Han; Han, Hye Sook

Efficacy and safety of lenvatinib vs sorafenib in hepatocellular carcinoma: A multi-center real-world study from the LINK Research Network 仑伐替尼与索拉非尼在肝细胞癌中的疗效与安全性比较：LINK研究网络的多中心真实世界研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Hong, J. Y.; Kang, M.; Sinn, D. H.; Cha, W. C.; Jeong, W. K.; Kim, D-Y.; Lee, M. J.; Lim, S.; Kim, D.; Kim, K-P.; Ryoo, B-Y.; Choi, W-M.; Kim, K.; Kim, K-H.; Choi, E. J.; Jung, C.; Lee, D.; Kim, J.

The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial 米奈利特单独或联合紫杉醇治疗晚期胃癌的安全性和有效性: I期试验

CANCER LETTERS

IF10.1

2024-08-01

PREAI

Lim, Sung Hee; Saluja, Ashok; Vickers, Selwyn; Hong, Jung Yong; Kim, Seung Tae; Lavania, Shweta; Pandey, Somnath; Gupta, Vineet K.; Velagapudi, Mohana R.; Lee, Jeeyun

Patient-derived tumor spheroid-induced angiogenesis preclinical platform for exploring therapeutic vulnerabilities in cancer

BIOMATERIALS

IF12.9

2024-04-01

PREAI

Ko, Jihoon; Hyung, Sujin; Heo, You Jeong; Jung, Sangmin; Kim, Seung Tae; Park, Se Hoon; Hong, Jung Yong; Lim, Sung Hee; Kim, Kyoung-Mee; Yoo, Sanghee; Li Jeon, Noo; Lee, Jeeyun

Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)在晚期胃癌患者中，三线免疫检查点抑制剂与基于伊立替康的化疗的真实世界结果: 韩国多中心研究 (KCSG ST22-06)

BMC CANCER

IF3.4

2024-02-23

OAAI

Lim, Sung Hee; Lee, Keun-Wook; Kim, Jae-Joon; Im, Hyeon-Su; Kim, In-Ho; Han, Hye Sook; Koo, Dong-Hoe; Cho, Jang Ho; Maeng, Chi Hoon; Lee, Min-Young; Lee, Hyo Jin; Kim, Jwa Hoon; Park, Sang Gon; Jung, Joo Young; Shin, Seong-Hoon; Kim, Ki Hyang; Kim, Hyeyeong; Oh, So Yeon; Kang, Minsu; Jung, Minkyu; Rha, Sun Young

Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: Real-World Data

BIOMEDICINES

IF3.9

2023-12-09

OAAI

Lim, Sung Hee; Jung, Jaeyun; Hong, Jung Young; Kim, Seung Tae; Park, Se Hoon; Park, Joon Oh; Kim, Kyoung-Mee; Lee, Jeeyun

The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric Cancer

gastric cancer

IF3.8

2023-01-01

OAAI

Jang, Jae Yeon; Jeon, Youngkyung; Jeong, Sun Young; Lim, Sung Hee; Kang, Won Ki; Lee, Jeeyun; Kim, Seung Tae

Effects of Omicron Infection and Changes in Serum Antibody Response to Wild-Type, Delta, and Omicron After a Booster Dose With BNT163b2 Vaccine in Korean Healthcare Workers

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2023-01-01

OAAI

Lim, Sung Hee; Kim, Han Jo; Kim, Se Hyung; Choi, Seong Hyeok; Kim, Bora; Kim, Ji Youn; Ji, Young Sok; Kim, Tark; Choo, Eun Ju; Jung, Jung Chan; Moon, Ji Eun; Kim, Chan Kyu; Park, Seong Kyu; Yun, Jina

Is Treosulfan-Based Conditioning Attractive as a Reduced-Intensity Conditioning Regimen in Korea?

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2023-01-01

OAAI

Kim, Se Hyung; Ji, Young Sok; Yun, Jina; Choi, Seong Hyeok; Lim, Sung Hee; Kim, Chan Kyu; Park, Seong Kyu

Eight-Month Follow-up After the Third Dose of BNT162b2 Vaccine in Healthcare Workers: The Question of a Fourth Dose

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2023-01-01

OAAI

Lim, Sung Hee; Choi, Seong Hyeok; Kim, Ji Youn; Kim, Bora; Kim, Han Jo; Kim, Se Hyung; Kim, Chan Kyu; Park, Seong Kyu; Yun, Jina

Serum Antibody Response Comparison and Adverse Reaction Analysis in Healthcare Workers Vaccinated with the BNT162b2 or ChAdOx1 COVID-19 Vaccine

VACCINES

IF3.4

2021-11-24

OAAI

Lim, Sung-Hee; Choi, Seong-Hyeok; Kim, Bora; Kim, Ji-Youn; Ji, Young-Sok; Kim, Se-Hyung; Kim, Chan-Kyu; Kim, Tark; Choo, Eun-Ju; Moon, Ji-Eun; Yun, Jina; Park, Seong-Kyu

Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)

ESMO OPEN

IF8.3

2021-04-01

OAAI

Park, H. S.; Kang, B.; Chon, H. J.; Im, H-S; Lee, C-K; Kim, I; Kang, M. J.; Hwang, J. E.; Bae, W. K.; Cheon, J.; Park, J. O.; Hong, J. Y.; Kang, J. H.; Kim, J. H.; Lim, S. H.; Kim, J. W.; Kim, J-W; Yoo, C.; Choi, H. J.

研究方向